EMA recommends marketing authorisation for veterinary vaccine, Bovilis Lumpyvax, for lumpy skin disease in cattle
The European Medicines Agency (EMA) has recommended granting a marketing authorisation in the EU for Bovilis Lumpyvax, a vaccine to protect cattle against lumpy skin disease by reducing clinical
Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.
Read full story on publisher site →